SHP2 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHP2 inhibitor, covering 2025-09-24 to 2025-09-24. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations [Phase 1]